Invus Global Management, LLC
SEC insider (Form 3/4/5 filer). CIK 0002005369. 10% Owner at Scholar Rock Holding Corp (SRRK) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in NEW YORK, NY.
Companies Invus Global Management, LLC has filed insider reports for
- Scholar Rock Holding Corp (SRRK): 10% Owner
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director, 10% Owner
Invus Global Management, LLC
CIK: 0002005369
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 2, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardIndirect18.6M shares at avg. $1.30$24.1M - Feb 2, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardIndirect3.8M shares at avg. $1.30$5.0M - Feb 2, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
PurchaseIndirect1.5M shares at avg. $1.30$2.0M - Feb 2, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardIndirect367.1K shares at avg. $65.00$23.9M - Dec 11, 2025SRRK
Scholar Rock Holding Corp
In-the-MoneyDirect1.6M shares at avg. $7.35$11.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 |  LXRX LEXICON PHARMACEUTICALS, INC. | Award | 18,553,846 | $1.30 | $24,120,000 | Indirect |
| Feb 2, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award | 3,846,154 | $1.30 | $5,000,000 | Indirect |
| Feb 2, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Purchase | 1,538,462 | $1.30 | $2,000,001 | Indirect |
| Feb 2, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award | 367,145 | $65.00 | $23,864,433 | Indirect |
| Dec 11, 2025 |  SRRK Scholar Rock Holding Corp | In-the-Money | 1,575,008 | $7.35 | $11,576,309 | Direct |
1-5 of 5 transactions